FLS or NDSN: Which Is the Better Value Stock Right Now?

Zacks Research identified Flowserve (FLS) as the superior value stock over Nordson (NDSN) within the Manufacturing - General Industrial sector, despite both holding a Zacks Rank #2 (Buy) due to positive earnings estimate revisions. FLS exhibits more attractive valuation metrics, including a forward P/E of 15.90, PEG of 1.10, and P/B of 3.08, compared to NDSN's higher figures of 21.93, 1.69, and 4.17, respectively. Consequently, FLS earned a Value grade of B, while NDSN received a D, indicating FLS as the better value opportunity.

Analysis

An analysis of two Manufacturing - General Industrial sector stocks, Flowserve (FLS) and Nordson (NDSN), reveals a clear preference for FLS from a value investment perspective, despite both companies holding a positive Zacks Rank #2 (Buy) status driven by favorable earnings estimate revisions. The differentiation lies entirely in their valuation metrics. Flowserve currently trades at a forward P/E of 15.90, supported by a PEG ratio of 1.10 and a P/B ratio of 3.08. In contrast, Nordson appears significantly more expensive with a forward P/E of 21.93, a PEG ratio of 1.69, and a P/B ratio of 4.17. This quantitative disparity is reflected in their respective Zacks Value grades, with FLS earning a 'B' while NDSN receives a 'D'. Consequently, while both firms exhibit improving earnings outlooks, the data positions FLS as the superior value opportunity at current price levels.

Key Decisions for Investors

• Value-oriented investors should consider Flowserve (FLS) a more attractive opportunity than Nordson (NDSN) given its substantially lower forward P/E, PEG, and P/B ratios.
• Investors holding Nordson (NDSN) should be aware of its premium valuation relative to peers and recognize that its investment case is not supported by traditional value metrics, as indicated by its 'D' value grade.
• Since the 'Buy' rating for both companies is contingent on positive earnings estimate revisions, investors should closely monitor future analyst estimates, as any negative revisions could significantly impact the investment thesis for either stock.